Bluefin Capital Management’s Pfizer PFE Stock Holding History

Bluefin Capital Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-270,100	Closed	-$5.15K	–	260
2023 Q4	$5.15K	Buy	+270,100	New	+$8.17M	﹤0.01%	195
2023 Q1	–	Sell	-101,600	Closed	-$1.96K	–	403
2022 Q4	$1.96K	Hold	101,600	–	–	﹤0.01%	416
2022 Q3	$9K	Sell	101,600 -12,000	-11%	-$583K	﹤0.01%	468
2022 Q2	$130K	Sell	113,600 -73,300	-39%	-$3.74M	0.01%	339
2022 Q1	$267K	Sell	186,900 -355,200	-66%	-$18.4M	0.02%	289
2021 Q4	$4.47M	Buy	542,100 +408,500	+306%	+$20.2M	0.31%	63
2021 Q3	$25K	Buy	+133,600	New	+$5.92M	﹤0.01%	605
2021 Q2	–	Sell	-20,000	Closed	-$6K	–	836
2021 Q1	$6K	Buy	+20,000	New	+$710K	﹤0.01%	720
2020 Q2	–	Sell	-26,350	Closed	-$88K	–	446
2020 Q1	$88K	Buy	+26,350	New	+$898K	0.01%	300
2019 Q4	–	Sell	-72,515	Closed	-$27K	–	702
2019 Q3	$27K	Buy	72,515 +39,946	+123%	+$1.45M	﹤0.01%	413
2019 Q2	$20K	Sell	32,569 -4,848	-13%	-$193K	﹤0.01%	289
2019 Q1	$33K	Buy	+37,417	New	+$1.5M	﹤0.01%	306
2018 Q4	–	Sell	-34,993	Closed	-$22K	–	511
2018 Q3	$22K	Buy	+34,993	New	+$1.35M	﹤0.01%	442
2017 Q2	–	Sell	-10,540	Closed	-$9K	–	579
2017 Q1	$9K	Buy	+10,540	New	+$332K	﹤0.01%	415
2016 Q3	–	Sell	-39,209	Closed	-$100K	–	549
2016 Q2	$100K	Buy	+39,209	New	+$1.25M	0.01%	331
2016 Q1	–	Sell	-316,200	Closed	-$108K	–	672
2015 Q4	$108K	Buy	+316,200	New	+$9.95M	0.01%	452
2015 Q2	–	Sell	-210,800	Closed	-$383K	–	508
2015 Q1	$383K	Buy	+210,800	New	+$6.7M	0.04%	299
2014 Q4	–	Sell	-52,700	Closed	-$2K	–	853
2014 Q3	$2K	Buy	+52,700	New	+$1.48M	﹤0.01%	915

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Bluefin Capital Management's PFE Position: Q2 2026 in Review

Bluefin Capital Management reduced its Pfizer (PFE) stake by 52% in Q2 2026, selling an estimated $541K and leaving 19,056 shares worth $459K. The position accounts for 0.12% of the portfolio, ranked #58.

Bluefin Capital Management first reported a position in PFE in Q2 2013 and has held it in 41 quarters since. The position peaked at $34.4M in Q2 2013. 2,836 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Bluefin Capital Management held 19,056 shares of Pfizer worth $459K as of Q2 2026.
Bluefin Capital Management sold 20,698 Pfizer shares in Q2 2026, an estimated $541K.
Pfizer made up 0.12% of Bluefin Capital Management's portfolio in Q2 2026, its #58 holding.
Bluefin Capital Management first reported a position in Pfizer in Q2 2013 and has held it in 41 quarters since.
Bluefin Capital Management's Pfizer position peaked at $34.4M in Q2 2013.
2,836 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Bluefin Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.